Free Trial

Hims & Hers Health (HIMS) Competitors

Hims & Hers Health logo
$49.40 -1.96 (-3.82%)
Closing price 10/21/2025 03:59 PM Eastern
Extended Trading
$49.46 +0.06 (+0.12%)
As of 07:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HIMS vs. NTRA, GH, RDNT, BTSG, SHC, OPCH, WGS, GRAL, PRVA, and CELC

Should you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), GRAIL (GRAL), Privia Health Group (PRVA), and Celcuity (CELC). These companies are all part of the "healthcare" industry.

Hims & Hers Health vs. Its Competitors

Hims & Hers Health (NYSE:HIMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

Hims & Hers Health has a net margin of 9.63% compared to Natera's net margin of -12.89%. Hims & Hers Health's return on equity of 26.26% beat Natera's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health9.63% 26.26% 13.06%
Natera -12.89%-22.22%-15.03%

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Comparatively, 5.6% of Natera shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Hims & Hers Health has a beta of 2.25, suggesting that its share price is 125% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.74, suggesting that its share price is 74% more volatile than the S&P 500.

Hims & Hers Health has higher earnings, but lower revenue than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$1.48B7.56$126.04M$0.8061.75
Natera$1.70B15.12-$190.43M-$1.91-97.84

Hims & Hers Health currently has a consensus price target of $38.92, suggesting a potential downside of 21.22%. Natera has a consensus price target of $196.81, suggesting a potential upside of 5.31%. Given Natera's stronger consensus rating and higher probable upside, analysts clearly believe Natera is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
3 Sell rating(s)
10 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.93
Natera
1 Sell rating(s)
1 Hold rating(s)
16 Buy rating(s)
1 Strong Buy rating(s)
2.89

In the previous week, Hims & Hers Health had 38 more articles in the media than Natera. MarketBeat recorded 55 mentions for Hims & Hers Health and 17 mentions for Natera. Natera's average media sentiment score of 0.87 beat Hims & Hers Health's score of 0.66 indicating that Natera is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
20 Very Positive mention(s)
13 Positive mention(s)
13 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Natera
9 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Hims & Hers Health beats Natera on 9 of the 17 factors compared between the two stocks.

Get Hims & Hers Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HIMS vs. The Competition

MetricHims & Hers HealthMEDICAL INFO SYS IndustryMedical SectorNYSE Exchange
Market Cap$11.61B$2.26B$6.22B$22.00B
Dividend YieldN/AN/A5.74%3.61%
P/E Ratio61.7537.6729.1432.73
Price / Sales7.5616.10589.4461.10
Price / Cash145.8461.1937.5124.48
Price / Book22.8712.4512.564.67
Net Income$126.04M-$64.36M$3.32B$1.02B
7 Day Performance-21.32%-3.42%0.73%-0.31%
1 Month Performance-14.48%2.46%7.29%-0.17%
1 Year Performance109.41%29.16%65.05%11.29%

Hims & Hers Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HIMS
Hims & Hers Health
2.3302 of 5 stars
$49.40
-3.8%
$38.92
-21.2%
+114.3%$11.61B$1.48B61.751,637Trending News
Analyst Forecast
Insider Trade
NTRA
Natera
2.0519 of 5 stars
$192.47
+5.9%
$196.81
+2.3%
+55.1%$26.40B$1.70B-100.704,434Short Interest ↑
GH
Guardant Health
3.8268 of 5 stars
$69.68
+6.4%
$65.86
-5.5%
+223.9%$8.70B$739.02M-20.832,021Upcoming Earnings
RDNT
RadNet
3.3995 of 5 stars
$78.85
+2.5%
$76.80
-2.6%
+19.7%$6.06B$1.83B-394.1811,021News Coverage
BTSG
BrightSpring Health Services
2.1375 of 5 stars
$30.26
+1.8%
$32.13
+6.2%
+100.4%$5.35B$11.27B97.4235,000Trending News
Earnings Report
Analyst Forecast
SHC
Sotera Health
2.6021 of 5 stars
$16.71
+3.4%
$17.20
+3.0%
+6.4%$4.75B$1.10B209.213,000News Coverage
OPCH
Option Care Health
4.7822 of 5 stars
$28.21
+1.6%
$35.10
+24.4%
-7.5%$4.59B$5.00B22.618,088Positive News
WGS
GeneDx
2.7642 of 5 stars
$125.82
+4.0%
$109.78
-12.7%
+109.3%$3.62B$305.45M2,519.301,200Upcoming Earnings
Analyst Forecast
GRAL
GRAIL
0.6776 of 5 stars
$91.67
+17.5%
$56.67
-38.2%
+477.7%$3.31B$125.60M-7.001,360Trending News
Gap Up
High Trading Volume
PRVA
Privia Health Group
3.0522 of 5 stars
$26.29
+3.0%
$28.91
+10.0%
+46.8%$3.23B$1.74B239.341,140Positive News
CELC
Celcuity
1.7776 of 5 stars
$70.78
+36.2%
$62.75
-11.3%
+306.1%$3.00BN/A-20.4740Trending News
Analyst Forecast
High Trading Volume

Related Companies and Tools


This page (NYSE:HIMS) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners